OWC Pharmaceutical Research Corp (OWCP)

[skitahoe]

I believe there is an easy, and a hard way of getting on the Nasdaq. The easy way is by building corporate value by successfully gaining patents, putting products through trials, and ultimately gaining drug approvals. In reality, if Phase 2 trial results indicate that the drug is worthy of approval, it will probably be sufficient to gain the $4 price that makes it to the Nasdaq.

The hard way is bizarre reverse splits that move up the share price, but typically have it fall back and still fail to meet Nasdaq requirements. If the share price doesn't fall back, a Nasdaq listing may be achieved quicker, but without success in trials, it won't stay there.

Investors generally don't like reverse splits, but if the company takes the easy way and gets the price to a couple dollars, investors could become enthused about taking a small shortcut and doing a 1 for 2 reverse split to qualify. That's a decision that could be made late this year, and more likely next, as more is known about both trials and patents. Achieving a share price of over $2 by then might even encourage investors to say, let's do a 1 for 2 to get on the Nasdaq now.

Of course one of the easiest ways of growing the share price has to do with communicating with investors, it's not something the company has generally chosen to do, but if they changed their mind and started telling investors where things stand, and where they're going, I suspect our price would be up substantially, and continue to rise as they updated us on progress. As always, it's JMHO.

Gary